TCTR20180417001
Terminated
Phase 1
Effectiveness of oxytocin intranasal on reducing alcohol consumption and depression syndrome in a patient with oropharyngeal carcinoma, a quasi-experimental single-case design structure
none0 sites1 target enrollmentApril 17, 2018
Overview
- Phase
- Phase 1
- Intervention
- Not specified
- Conditions
- All the data of this study were collected after agreement with the patient,
- Sponsor
- none
- Enrollment
- 1
- Status
- Terminated
- Last Updated
- last year
Overview
Brief Summary
No summary available.
Investigators
Eligibility Criteria
Inclusion Criteria
- •single\-case design structure
Exclusion Criteria
- •single\-case design structure
Outcomes
Primary Outcomes
Not specified
Similar Trials
Active, not recruiting
Not Applicable
Effects of intranasal application of oxytocin on empathy and mentalising in patients with psychotic disorders and severe personality disordersEUCTR2007-006561-32-DEWL University Hospital Bochum
Not yet recruiting
Phase 2
Oxytocin & benzodiazepines2024-516262-11-00St. Olavs Hospital HF60
Completed
Phase 2
intranasal oxytocin in the treatment of schizophreniaschizophrenia.schizophreniaIRCT201202251556N35Tehran University of Medical Sciences40
Recruiting
Phase 2
Effects of Intranasal Oxytocin in the Treatment of Benzodiazepine Withdrawal: A Pilot RCTBenzodiazepine DependenceNCT06757517St. Olavs Hospital60
Completed
Phase 3
Evaluation of Intranasal oxytocine spray effect on preventing post-dural puncture headache after cesarean sectiopost-dural puncture headache.Spinal and epidural anesthesia-induced headache during the puerperiumO89.4IRCT20201215049725N1Karaj University of Medical Sciences170